Overnight Market report, page-127

No argument with those views people however I reckon that in reality Mr Market only really gets back to the office next week and even then will take a few days to get used to the tie and new shoes before he really starts to crack the whip ! Lets see where we are by end of next week. Would be great to get a surprise soon of some (any) solid data - thought it was interesting that even MV noted he would like a bit of a rerate that I believe was anticipated last year. My memory is that not long after taking on the job MV indicated the company would not just look at cancer but more broadly at the auto immune segment - smart then smart now. Just watched a relatively recent interview with the CEO of Pfizer who suggested we are at the front end of a pharma / medical treatment renaissance. I took that as meaning both from discovery / development and the way in which players of all sizes come together to bring solutions to market. We live in interesting times.